Article
ATP13A2 deficiency disrupts lysosomal polyamine export.
Nature - 1 Feb 2020
van Veen Sarah, Martin Shaun, Van den Haute Chris, Benoy Veronick, Lyons Joseph, Vanhoutte Roeland, Kahler Jan Pascal, Decuypere Jean-Paul, Gelders Géraldine, Lambie Eric, Zielich Jeffrey, Swinnen Johannes V, Annaert Wim, Agostinis Patrizia, Ghesquière Bart, Verhelst Steven, Baekelandt Veerle, Eggermont Jan, Vangheluwe Peter
Abstract excerpt
ATP13A2 (PARK9) is a late endolysosomal transporter that is genetically implicated in a spectrum of neurodegenerative disorders, including Kufor-Rakeb syndrome-a parkinsonism with dementia1-and early-onset Parkinson's disease2. ATP13A2 offers protection against genetic and environmental risk factors of Parkinson's disease, whereas loss of ATP13A2 compromises lysosomes3. However, the transport function of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
